longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Weekly Recap | Trilogy Mets -0.31%, most brokers rate it buy

Weekly Review
Sep 19, 2026 at 06:54 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Trilogy Metals (TMQ) fell 0.31% this week to close at $3.26, underperforming the S&P 500’s 0.08% decline by roughly 0.23 percentage points. The week opened at $3.30 on Monday and touched a high of $3.33 before pulling back; Wednesday marked the low at $3.05, with Thursday and Friday recovering to $3.24 and $3.26. The weekly range was 8.48%, and average daily volume of about 1.24m shares ran 4.13% above the 60-day median.

The Week

Trilogy Metals (TMQ) fell 0.31% this week to close at $3.26, underperforming the S&P 500’s 0.08% decline by roughly 0.23 percentage points. The week opened at $3.30 on Monday and touched a high of $3.33 before pulling back; Wednesday marked the low at $3.05, with Thursday and Friday recovering to $3.24 and $3.26. The weekly range was 8.48%, and average daily volume of about 1.24m shares ran 4.13% above the 60-day median.

Key Events

The main company update came early Tuesday: Trilogy Metals closed a $17.8 million strategic investment from the U.S. Department of War and signed ancillary pacts. Later that day, several broader pieces covered corporate spending shifts across tech and consumer names, as well as moves in fringe US assets such as yen ETFs and defence-linked names against a backdrop of cross-border macro tensions. The company-specific news was concentrated in the strategic funding announcement, while the other items were market-level observations with no clear directional link to the share price.

Analyst Ratings

Six firms cover the stock: two rate it buy, one rates it overweight and three rate it hold, with no sell or underweight ratings. A separate aggregation shows two strong buy, one buy and three hold ratings, with an overall recommendation of buy. The consensus target price of $6.62 sits 103.21% above spot, while individual targets range from $4.36 to $10.02, reflecting a wide dispersion in valuation views. The stock ranks 18th among 64 companies in the diversified metals and mining industry.

The Week Ahead

There were no material company filings this week, so attention turns to US macro data. On Tuesday 22 September the Richmond Fed composite index is due, with the prior reading at 4. On Wednesday 23 September the EIA releases weekly crude oil and Cushing inventory figures. Thursday 24 September brings initial jobless claims, the current account balance, new home sales and the EIA natural gas storage change. If macro releases move industrial metals and resource sentiment, TMQ could track those swings, though the company itself has no scheduled catalysts.

In Short

TMQ traded in a narrow range after closing its strategic investment, finishing the week 0.23 percentage points behind the S&P 500. The analyst picture is positive: the consensus rating remains buy and the consensus target sits far above spot. At the same time, the price is in the lower half of its 60-day range, and the latest session’s capital flow shows buying across large, medium and small orders. The key question is whether macro data next week shifts resource-sector sentiment enough to test that bullish target.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.

Login to unlock2,268characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Trilogy Mets

Trilogy Mets

TMQ.US

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--

LongbridgeAI